title: Iron metabolism and fungal infections in patients with haematological malignancies.
abstract: OBJECTIVE
  To determine whether iron metabolism influences the incidence of systemic fungal infection in patients with haematological malignancies.
  
  
  METHODS
  The study population comprised 74 patients who had undergone myeloablative chemotherapy. Systemic fungal infections were classified as confirmed (histological confirmation or characteristic septate hyphae) or possible (antibiotic resistant fever which resolved following administration of intravenous amphotericin B, together with either typical radiographic lesions or massive oropharyngeal candidiasis). Parameters of iron metabolism included serum iron concentrations, total iron binding capacity, serum transferrin, and ferritin concentrations and transferrin saturation values.
  
  
  RESULTS
  Patients who developed a fungal infection had substantially increased transferrin saturation values and ferritin concentrations at diagnosis together with low serum transferrin and high serum iron concentrations. This profile was present in patients with a fungal infection regardless of the underlying haematological disorder.
  
  
  CONCLUSIONS
  Increased transferrin saturation values and high ferritin concentrations may be additional risk factors for the development of systemic fungal infection in patients with haematological malignancies.
authors.affiliation: Departamento de Medicina, Hospital Universitario, Universidad de Salamanca, Paseo San Vicente, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Iglesias-Osma
authors.forename: L
authors.initials: L
authors.lastname: Gonzalez-Villaron
authors.forename: J F
authors.initials: JF
authors.lastname: San Miguel
authors.forename: M D
authors.initials: MD
authors.lastname: Caballero
authors.forename: L
authors.initials: L
authors.lastname: Vazquez
authors.forename: S
authors.initials: S
authors.lastname: de Castro
mesh_terms: D000208:Acute Disease; D005293:Ferritins / Q000097:blood; D006801:Humans; D007501:Iron / Q000097:blood*; D007938:Leukemia / Q000097:blood* / Q000150:complications; D007951:Leukemia, Myeloid / Q000097:blood; D008223:Lymphoma / Q000097:blood* / Q000150:complications; D009181:Mycoses / Q000097:blood* / Q000150:complications; D009894:Opportunistic Infections / Q000097:blood* / Q000150:complications; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood; D012189:Retrospective Studies; D014168:Transferrin / Q000378:metabolism
chemical_list: D014168:Transferrin; D005293:Ferritins; D007501:Iron